1. Home
  2. PROK vs EVI Comparison

PROK vs EVI Comparison

Compare PROK & EVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROK
  • EVI
  • Stock Information
  • Founded
  • PROK 2015
  • EVI 1959
  • Country
  • PROK United States
  • EVI United States
  • Employees
  • PROK N/A
  • EVI N/A
  • Industry
  • PROK Biotechnology: Biological Products (No Diagnostic Substances)
  • EVI Other Consumer Services
  • Sector
  • PROK Health Care
  • EVI Consumer Discretionary
  • Exchange
  • PROK Nasdaq
  • EVI Nasdaq
  • Market Cap
  • PROK 417.1M
  • EVI 353.9M
  • IPO Year
  • PROK N/A
  • EVI N/A
  • Fundamental
  • Price
  • PROK $2.97
  • EVI $27.27
  • Analyst Decision
  • PROK Strong Buy
  • EVI Strong Buy
  • Analyst Count
  • PROK 4
  • EVI 1
  • Target Price
  • PROK $6.25
  • EVI $33.00
  • AVG Volume (30 Days)
  • PROK 2.1M
  • EVI 21.8K
  • Earning Date
  • PROK 11-11-2025
  • EVI 11-11-2025
  • Dividend Yield
  • PROK N/A
  • EVI 1.20%
  • EPS Growth
  • PROK N/A
  • EVI 32.43
  • EPS
  • PROK N/A
  • EVI 0.49
  • Revenue
  • PROK $527,000.00
  • EVI $389,830,000.00
  • Revenue This Year
  • PROK $427.89
  • EVI $14.10
  • Revenue Next Year
  • PROK N/A
  • EVI $4.00
  • P/E Ratio
  • PROK N/A
  • EVI $56.31
  • Revenue Growth
  • PROK N/A
  • EVI 10.26
  • 52 Week Low
  • PROK $0.46
  • EVI $14.99
  • 52 Week High
  • PROK $7.13
  • EVI $34.82
  • Technical
  • Relative Strength Index (RSI)
  • PROK 55.05
  • EVI 41.14
  • Support Level
  • PROK $2.80
  • EVI $26.17
  • Resistance Level
  • PROK $3.28
  • EVI $29.42
  • Average True Range (ATR)
  • PROK 0.27
  • EVI 2.02
  • MACD
  • PROK 0.01
  • EVI -0.55
  • Stochastic Oscillator
  • PROK 57.52
  • EVI 18.52

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

About EVI EVI Industries Inc.

EVI Industries Inc through its subsidiaries, is a distributor that sells, leases, and rents commercial, industrial, and vended laundry and dry cleaning equipment and steam and hot water boilers manufactured by others, supplies related replacement parts and accessories, designs and plans turn-key laundry, dry cleaning, and boiler systems, and provides installation and maintenance services to its customers, which include commercial, industrial, institutional, government, and retail customers. These activities are conducted in the United States, Canada, the Caribbean, and Latin America.

Share on Social Networks: